In-Person
Redefining MAS OTC Derivatives
15 May, 2025
Share
Event Details
Date & Time
15 May, 2025, 10:30 – 1:30 SGT
Location
In-Person
Join us for the Enfusion Client Forum, where we will explore the evolving MAS OTC derivatives reporting requirements. This event will provide valuable insights to help your firm navigate compliance requirements and optimize reporting workflows.
Note: There is a limit on the number of attendees per firm. Places are allocated on a first-come, first-served basis
Additionally, stay ahead of the curve with the latest emerging trends and opportunities as Singapore Exchange presents the latest developments in their Derivatives and Securities markets, including an overview of the recently unveiled MAS Review Group measures directed at invigorating Singapore’s Equity market.
Keynote Agenda
- Navigating Volatility: Singapore Exchange’s Round-the-Clock & Holiday Trading
- Rejuvenating Singapore's Equity Market: MAS Review Group Measures and Recent Themes.
Speakers
Meiyan Ding
Head of Equity Derivatives Products Global Markets
Singapore Exchange
Bliss Chang
Director of Securities Trading, Equities-Securities
Singapore Exchange
Jonathan Chee
Vice President, Head of Account Management (Hong Kong)
Enfusion
Sinyee Koh
Director
Integrity Consulting
Faizal Aziz
Head of Business Change & Regulatory Relations
S&P Global Market Intelligence CappiTech